To The Editor

During the COVID-19 pandemic, eosinopenia was described by Li et al. as a hallmark of this infection in patients presenting with fever [@bib0001]. For the prediction of positive SARS-CoV-2 cases (diagnosis based on RT-PCR), eosinopenia has a sensitivity of 74.7% and specificity of 68.7% with the area under the curve AUC of 0.717. The combination of eosinopenia and raised hs-CRP yielded a sensitivity of 67·9% and specificity of 78·2% (AUC = 0·730).

Up until end of March 20, Seasonal Influenza and COVID-19 were simultaneously present in Europe. These two infections share similar clinical and biological features and co-infections can exist [@bib0002]. We reviewed the laboratory results of two cohorts of SARS-CoV-2 (*N* = 50) and Influenza A (*N* = 41) patients (diagnosis confirmed by RT PCR). On admission, 69 patients (76% of both groups) had a total eosinophil count lower than 50/µl and 44 patients (48% of both groups) had an undetectable eosinophil count (see [Table 1](#tbl0001){ref-type="table"}). Upon closer examination, in the COVID-19 group, there were more reported cases of complete eosinopenia. Moderately low basophils and monocytes count were also a common finding.Table 1Epidemiological and laboratory characteristics of the study population[\*](#tb1fn1){ref-type="table-fn"}.Table 1Whole population (*n* = 91, 48 M/43 F)COVID 19 (*n* = 50, 31 M/19 F)Type A Influenza (*n* = 41, 17 M/24 F)p-value[⁎⁎](#tb1fn2){ref-type="table-fn"}**Age (years)**63.0 ± 16.063.2 ± 12.862.9 ± 19.4NS**Hb (g/dL)**12.3 ± 2.012.6 ± 1.811.9 ± 2.2NS**WBC (10^3^/µL)**8043 ± 39537029 ± 38528239 ± 4410NS**Neutrophils (/µL)**6201 ± 36655712 ± 33956075 ± 3880NS**Lymphocytes (/µL)**828 ± 377894 ± 415998± 893NS**Monocytes (/µL)**529 ± 417449 ± 298716 ± 5150,003**Eosinophils**32 ± 8427 ± 7549 ± 72NS**(Eo) (/µL)**10*0*100.01ᶧ***Median (/*µL*)***44 (48%)*30 (60%)*14 (34%)***Eo Not measurable (n=,%)***69 (76%)*43 (86%)*26 (63%)***Eo \< 50/µL***22 (24%)*7 (14%)*15 (37%)***(n=,%)**Eo ≥ 50/µL**(n=,%)*Basophils(/µL)**21 ± 1819 ± 2031 ± 290,01**Platelets(10^3^/µL)**222 ± 110218 ± 112208 ± 96NSCRP (mg/L)164 ± 125133.9 ± 101.196 ± 118NS[^1][^2][^3]

As such from the above, we can reach to the conclusion that complete eosinopenia is a common finding in both COVID-19 and Seasonal Influenza infections. Thus result could imply that eosinopenia could be considered as a potential biological indicator of either Influenza or SARS-COV-2 infections. This could be very useful when both diseases are prevalent at the same time. Moreover, as shown by Li et al., severe cases of eosinopenia should raise the suspicion of a COVID-19 infection, outside of the flu season.
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[^1]: ICU= intensive care unit, *M*= males, *F*= females, SD= standard deviation, WBC= white blood cells, CRP= *C*-reactive protein.

[^2]: Mean Value ± SD.

[^3]: T-test, ᶧ chi-squared test for percentage comparison.
